minor thalassemia. Thalassaemia, unspecified
Conditions
Interventions
Intervention 1: Intervention group: We prescribe 1 milligram Folic acid daily in morning fasting for six months in ?intervention group. ?. Intervention 2: control group:We prescribe placebo daily in
Treatment - Drugs
Intervention group: We prescribe 1 milligram Folic acid daily in morning fasting for six months in ?intervention group. ?
control group:We prescribe placebo daily in morning fasting for six ?months in control group. ?
Sponsors
Vice chancellor for research, Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
5 Years to 15 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: children 5-15 years of age with thalassemia Exclusion criteria: iron deficiency anemia and thalassemia minor, underlying disease, lack of compliance to medication
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Well being of children. Timepoint: start and six months after study. Method of measurement: Psychological testing ?.;Complete blood cells ?. Timepoint: first and 6 months after. Method of measurement: Blood test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Aziz Eghbali
Arak University of Medical Sciences
Outcome results
None listed